Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Alexandria Clark Podcasts

show episodes
 
This podcast is about interviewing different intriguing books that will make you want to jump out of your seat and get your read on! Cover art photo provided by Dakota Corbin on Unsplash: https://unsplash.com/@thedakotacorbin
  continue reading
 
Join Kojo and resident analyst Tom Sherwood on Fridays at noon for our weekly review of the politics, policies and personalities in the District of Columbia, Maryland, and Virginia. Each week Kojo and Tom help make sense of legislation, hold elected officials accountable and provide in-depth analysis of local issues and elections. The Politics Hour is also a vital forum for Washingtonians to engage directly with their local leaders.
  continue reading
 
Loading …
show series
 
As Metro wrestles with a murky financial future, local leaders making up the DMV Moves task force are debating what a dedicated, predictable funding model might look like for the region's public transportation. Options on the table include a regional sales tax, higher vehicle registration fees, and increasing income taxes. Maryland State Delegate M…
  continue reading
 
When 26-year-old Markinson suffered a psychotic break, he was given a choice no one should ever face: participate in a clinical trial or face long-term involuntary confinement. What followed was a tragic chain of events—his worsening condition, the helpless fight of a mother trying to save her son, and ultimately, a suicide that would spark a natio…
  continue reading
 
Long-time Virginia Congressman Gerry Connolly passed away unexpectedly this week. He was a fierce advocate for federal workers, a former chair of the Fairfax County Board of Supervisors, and a frequent guest on The Politics Hour. Former U.S. Representative Tom Davis - and the man who held the 11th congressional district seat before Connolly was ele…
  continue reading
 
Virginia's primary races are heating up, most notably the lieutenant governor's race. While the Republicans have a presumptive nominee, six Democratic candidates are vying for the post. WAMU's Northern Virginia Reporter Margaret Barthel broke down the lieutenant governor's race, as well as the Democratic candidates for attorney general. She also sh…
  continue reading
 
In this chilling episode of Dark History of Clinical Trials, we explore the devastating 2016 Phase 1 clinical trial in Rennes, France, that left one man dead and several others with lasting neurological damage. Designed to test a new painkiller, the study went catastrophically wrong after investigators escalated the dose without properly analyzing …
  continue reading
 
D.C. Mayor Muriel Bowser proposed repealing Initiative 82 earlier this week, reigniting the fight over D.C.'s tipped minimum wage law. But given that voters passed the measure twice, the mayor could have trouble getting support from the D.C. Council. Chairman Phil Mendelson got behind the mic to give his thoughts. He said overturning Initiative 82 …
  continue reading
 
On Monday, the District announced the city had struck a nearly $4 billion deal with the Washington Commanders to build a new football stadium and a massive mixed-use development at the old RFK site. The city is chipping in about $1 billion in infrastructure improvements to the site, including two parking facilities. D.C. Mayor Muriel Bowser joined …
  continue reading
 
D.C. Mayor Muriel Bowser and the Washington Commanders are reportedly close to striking a $3 billion deal to build a new football stadium anchoring a massive mixed-use development at the old RFK site. It's believed to include at least $850 million from the District for parking and preparing the site, with the team paying to build the stadium itself…
  continue reading
 
In Part 3 of our series on government-funded clinical trials, we shift the focus to the upsides of working in publicly funded research. From greater patient diversity and broader public health impact to mission-driven work and long-term study follow-through, we highlight what makes this space both rewarding and unique. We also explore what kind of …
  continue reading
 
D.C. and the Washington Commanders are reportedly closing in on a $3 billion deal to build a new stadium on the old RFK stadium site, which would bring the NFL franchise back to the District. While numbers reportedly are not finalized yet, the framework has the team paying a majority of the costs associated with building the new stadium. NBC 4's Ma…
  continue reading
 
Alexandria is dealing with the impacts of a shrinking federal workforce on its economy, tax base, and ability to fund even some basic services. Mayor Alyia Gaskins sat down with Kojo and Tom to discuss the local challenges that come with cutting thousands of federal positions. Plus, Mayor Gaskins explained why Alexandria is not a sanctuary city. Wa…
  continue reading
 
In this continuation of our deep dive into government-funded clinical trials, we explore real-world examples of how these studies operate differently from private pharma-sponsored research. Our guest shares firsthand insights into challenges like proving adverse events without medical records, navigating patient compensation differences, and the di…
  continue reading
 
The Trump administration laid off thousands of employees working at federal health agencies this week, including many at the National Institutes of Health in Montgomery County. The firings are expected to have far-ranging effects on the local workforce, county revenue, and public health. County Executive Marc Elrich joined Kojo and Tom to discuss w…
  continue reading
 
Part 1: Regulatory In this episode, we sit down with a clinical research coordinator from a government-funded hospital to explore the unique challenges and regulatory differences between publicly funded and private pharmaceutical company-sponsored trials. We discuss key topics such as study selection, start-up timelines, and the distinct approval p…
  continue reading
 
President Trump signed an executive order Thursday night aimed at reducing crime and increasing immigration enforcement in the District. Kojo and Tom talked about what it means for D.C. and what might happen next. Maryland is on the verge of approving its state budget, but it came with contentious debate over tax increases, cuts, and changes to its…
  continue reading
 
Episode 7: Big Pharma… in a Kitchen?! 🍳💊🚔 What happens when a man decides to skip the lab, the regulations, and basic ethics—and mass-produce fake medication in his own kitchen? The FDA found out. And let’s just say… he fked around and definitely found out. In this episode, we unravel the insane true story of a DIY “pharmaceutical empire,” the dang…
  continue reading
 
Not all medical disasters stem from unethical research—sometimes, even the most promising trials take a devastating turn. In this episode, we examine a clinical trial that had a flawless safety profile in pre-clinical testing but went horribly wrong when tested in humans. What critical mistakes were made? How did the researchers miss the warning si…
  continue reading
 
In this episode, we uncover the shocking and often tragic history of clinical trials gone wrong. These cases exposed the dire need for ethical oversight in medical research. But from these dark moments came progress: the Belmont Report, informed consent, and strict regulations that protect patients today. Join us as we explore how past mistakes sha…
  continue reading
 
In this episode of Tea in STEM, we're joined by Nikki Jundt, a seasoned regulatory specialist, to delve into the complexities of Investigator Site File (ISF) maintenance. Nikki shares her expertise and highlights critical challenges faced by research sites, drawing from her recent experience on a CDISC conference panel alongside FDA auditors and CR…
  continue reading
 
In Part 2 of our discussion on the FDA’s new guidance for clinical trials, we move from theory to practice. Ted B. from Medvector joins us again to dive into solutions for addressing potential challenges when implementing this new flexibility allowing healthcare providers (HCPs) to conduct visits with Principal Investigator (PI) oversight.…
  continue reading
 
In this episode, we dive into the latest FDA guidance expanding flexibility for clinical trials by allowing healthcare providers (HCPs) to conduct visits under Principal Investigator (PI) oversight. What does this mean for patients, research sites, and sponsors? Join us as we sit down with Ted Barduson, COO and Co-founder of Medvector to discuss th…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play